Authors:
Azizuddin, K
Kalka, K
Chiu, SM
Ahmad, N
Mukhtar, H
Separovic, D
Citation: K. Azizuddin et al., Recombinant human tumor necrosis factor alpha does not potentiate cell killing after photodynamic therapy with a silicon phthalocyanine in A431 humanepidermoid carcinoma cells, INT J ONCOL, 18(2), 2001, pp. 411-415
Citation: N. Ahmad et al., In vitro and in vivo inhibition of epidermal growth factor receptor-tyrosine kinase pathway by photodynamic therapy, ONCOGENE, 20(18), 2001, pp. 2314-2317
Authors:
Frank, J
Jugert, FK
Merk, HF
Kalka, K
Goerz, G
Anderson, K
Bickers, DR
Poh-Fitzpatrick, MB
Christiano, AM
Citation: J. Frank et al., A spectrum of novel mutations in the protoporphyrinogen oxidase gene in 13families with variegate porphyria, J INVES DER, 116(5), 2001, pp. 821-823
Authors:
Kalka, K
Mukhtar, H
Turowski-Wanke, A
Merk, H
Citation: K. Kalka et al., Biomelanin antioxidants in cosmetics: Assessment based on inhibition of lipid peroxidation, SKIN PH APP, 13(3-4), 2000, pp. 143-149
Authors:
Kalka, K
Ahmad, N
Criswell, T
Boothman, D
Mukhtar, H
Citation: K. Kalka et al., Up-regulation of clusterin during phthalocyanine 4 photodynamic therapy-mediated apoptosis of tumor cells and ablation of mouse skin tumors, CANCER RES, 60(21), 2000, pp. 5984-5987
Authors:
Frank, J
Nelson, J
Wang, XH
Yang, L
Ahmad, W
Lam, H
Jugert, FK
Kalka, K
Poh-Fitzpatrick, MB
Goerz, G
Merk, HF
Christiano, AM
Citation: J. Frank et al., Erythropoietic protoporphyria: Identification of novel mutations in the ferrochelatase gene and comparison of biochemical markers versus molecular analysis as diagnostic strategies, J INVES MED, 47(6), 1999, pp. 278-284